TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vaccinkliniken Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
508
|
563
|
736 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
57
|
59
|
186 |
| EBITDA |
58
|
60
|
188 |
| Total assets |
192
|
180
|
222 |
| Current assets |
192
|
178
|
219 |
| Current liabilities |
31
|
57
|
110 |
| Equity capital |
161
|
123
|
112 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
2
|
5
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
83.9%
|
68.3%
|
50.5% |
| Turnover per employee |
254
|
113
|
105 |
| Profit as a percentage of turnover |
11.2%
|
10.5%
|
25.3% |
| Return on assets (ROA) |
30.2%
|
32.8%
|
83.8% |
| Current ratio |
619.4%
|
312.3%
|
199.1% |
| Return on equity (ROE) |
35.4%
|
48.0%
|
166.1% |
| Change turnover |
-36
|
-175
|
-331 |
| Change turnover % |
-7%
|
-24%
|
-31% |
| Chg. No. of employees |
-3
|
-2
|
-3 |
| Chg. No. of employees % |
-60%
|
-29%
|
-30% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.